Literature DB >> 34884279

Functional Changes of the Genitourinary and Gastrointestinal Systems before and after the Treatment of Endometrial Cancer-A Systematic Review.

Marcin Oplawski1,2, Agata Średnicka1, Aleksandra Dutka1, Sabina Tim3, Agnieszka Mazur-Bialy1,3.   

Abstract

The incidence of endometrial cancer (EC), which coexists with such civilization diseases as diabetes, obesity or hypertension, is constantly increasing. Treatment includes surgery as well as brachytherapy, teletherapy, rarely chemotherapy or hormone therapy. Due to the good results of the treatment, the occurrence of side effects of therapy becomes a problem for the patients. One of the large groups of side effects includes the pelvic organ prolapse, urinary and fecal incontinence. The aim of this study was to present current knowledge on the occurrence of pelvic floor dysfunction in women treated for EC. A literature review was conducted in the PubMED and WoS databases, including articles on pelvic floor dysfunction in women with EC. PRISMA principles were followed in the research methodology. A total of 1361 publications were retrieved. Based on the inclusion and exclusion criteria, 24 papers were eligible for the review. Mostly retrospective studies based on different questionnaires were evaluated. No prospective studies were found in which, in addition to subjective assessment, clinical examination and objective assessment of urinary incontinence were used. Studies show a significant increase in the incidence of pelvic floor disorders, including urinary incontinence, after various forms of EC treatment. We believe that assessment of complications after endometrial cancer treatment is clinically relevant. The review emphasizes the importance of programming prospective studies to prevent and address these disorders at each stage of oncologic treatment.

Entities:  

Keywords:  LUTS; OAB; POP; endometrial cancer; overactive bladder; pelvic floor prolapse; urinary incontinence

Year:  2021        PMID: 34884279      PMCID: PMC8658546          DOI: 10.3390/jcm10235579

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  51 in total

1.  Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.

Authors:  Stephanie M de Boer; Melanie E Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Christine Haie-Meder; Petronella B Ottevanger; Jonathan A Ledermann; Pearly Khaw; Alessandro Colombo; Anthony Fyles; Marie-Helene Baron; Henry C Kitchener; Hans W Nijman; Roy F Kruitwagen; Remi A Nout; Karen W Verhoeven-Adema; Vincent T Smit; Hein Putter; Carien L Creutzberg
Journal:  Lancet Oncol       Date:  2016-07-07       Impact factor: 41.316

2.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 3.  Risk factors for endometrial cancer: An umbrella review of the literature.

Authors:  Olivia Raglan; Ilkka Kalliala; Georgios Markozannes; Sofia Cividini; Marc J Gunter; Jaya Nautiyal; Hani Gabra; Evangelos Paraskevaidis; Pierre Martin-Hirsch; Kostas K Tsilidis; Maria Kyrgiou
Journal:  Int J Cancer       Date:  2019-02-20       Impact factor: 7.396

4.  Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial.

Authors:  Remi A Nout; Lonneke V van de Poll-Franse; Marnix L M Lybeert; Carla C Wárlám-Rodenhuis; Jan J Jobsen; Jan Willem M Mens; Ludy C H W Lutgens; Betty Pras; Wim L J van Putten; Carien L Creutzberg
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

Review 5.  Endometrial cancer.

Authors:  Philippe Morice; Alexandra Leary; Carien Creutzberg; Nadeem Abu-Rustum; Emile Darai
Journal:  Lancet       Date:  2015-09-06       Impact factor: 79.321

6.  Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.

Authors:  Greg Kauffmann; Tianming Wu; Hania Al-Hallaq; Yasmin Hasan
Journal:  Brachytherapy       Date:  2016-11-18       Impact factor: 2.362

Review 7.  Urinary incontinence in women.

Authors:  Yoshitaka Aoki; Heidi W Brown; Linda Brubaker; Jean Nicolas Cornu; J Oliver Daly; Rufus Cartwright
Journal:  Nat Rev Dis Primers       Date:  2017-07-06       Impact factor: 52.329

Review 8.  Urinary Incontinence in Women: Modern Methods of Physiotherapy as a Support for Surgical Treatment or Independent Therapy.

Authors:  Agnieszka Irena Mazur-Bialy; Daria Kołomańska-Bogucka; Caroline Nowakowski; Sabina Tim
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

9.  Impact of gynecologic cancer on pelvic floor disorder symptoms and quality of life: an observational study.

Authors:  Mathias Neron; Sophie Bastide; Renaud de Tayrac; Florent Masia; Catherine Ferrer; Majd Labaki; Laurent Boileau; Vincent Letouzey; Stephanie Huberlant
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.